enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Morgan Stanley Doubles Vir Biotechnology Price Forecast ...

   www.aol.com/morgan-stanley-doubles-vir...

   On Wednesday, Vir Biotechnology, Inc. (NASDAQ:VIR) presented initial Phase 1 data from two of its dual-masked T-cell engagers (TCEs): VIR-5818, which targets a variety of HER2-expressing solid ...

3. What's Going On With Liver Disease Focused Vir Biotechnology ...

   www.aol.com/finance/whats-going-liver-disease...

   On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study evaluating combinations of tobevibart and elebsiran, with or without ...

4. Why Is Infectious Disease-Focused Vir Biotechnology Stock ...

   www.aol.com/finance/why-infectious-disease...

   On Wednesday, Vir Biotechnology Inc (NASDAQ:VIR) announced new preliminary data from its Phase 2 SOLSTICE hepatitis delta clinical trial evaluating tobevibart and elebsiran for chronic hepatitis ...

5. Vir Biotechnology, Inc. (VIR) Reports Next Week: Wall Street ...

   www.aol.com/news/vir-biotechnology-inc-vir...

   For premium support please call: 800-290-4726 more ways to reach us

6. This Hepatitis Stock Has 'Multiple Paths To Value Creation ...

   www.aol.com/news/hepatitis-stock-multiple-paths...

   SVB Leerink initiated coverage on Vir Biotechnology Inc (NASDAQ: VIR) with an Outperform rating and a price target of $40, with an investment thesis based on: With multiple clinic programs, Vir is ...

7. Vir Biotechnology, Inc. (VIR) Soars 15.1%: Is Further Upside ...

   www.aol.com/news/vir-biotechnology-inc-vir-soars...

   Vir Biotechnology, Inc. (VIR) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the ...

8. Biotech Stock Roundup: VIR Down on Regulatory News, BMY ... - AOL

   www.aol.com/news/biotech-stock-roundup-vir-down...

   For premium support please call: 800-290-4726 more ways to reach us

9. With 49% stake, Vir Biotechnology, Inc. (NASDAQ:VIR) seems to ...

   www.aol.com/news/49-stake-vir-biotechnology-inc...

   If you want to know who really controls Vir Biotechnology, Inc. ( NASDAQ:VIR ), then you'll have to look at the makeup...